Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial

Những quyển sách tương tự

• Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
  Bằng: Armstrong, M, et al.
  Được phát hành: (2015)
• Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
  Bằng: Armstrong, M, et al.
  Được phát hành: (2013)
• Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
  Bằng: Armstrong, M, et al.
  Được phát hành: (2013)
• Orlistat for overweight subjects with nonalcoholic steatohepatitis.
  Bằng: Dowman, J, et al.
  Được phát hành: (2009)
• Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
  Bằng: Armstrong, M, et al.
  Được phát hành: (2014)